Release: GRAND CANYON EDUCATION ALERT Bragar Eagel & Squire, P.C. is Investigating Grand Canyon Education, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Release

GRAND CANYON EDUCATION ALERT Bragar Eagel & Squire, P.C. is Investigating Grand Canyon Education, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

28 January 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against Grand Canyon Education, Inc. (NASDAQ:LOPE) on behalf of Grand Canyon Education stockholders. Our investigation concerns whether Grand Canyon Education has violated the federal securities laws and/or engaged in other unlawful business practices.

Read full release.

 

Release: DEADLINE ALERT Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm

Release

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm

19 September 2019

Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all investors that purchased Karyopharm, Inc. (NASDAQ: KPTI) securities between March 2, 2017 to February 22, 2019 (the “Class Period”). Investors have until September 23, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Release: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Abiomed, Inc. (NASDAQ: AMBD) and Encourages Abiomed Investors to Contact the Firm

Release

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Abiomed, Inc. (NASDAQ: AMBD) and Encourages Abiomed Investors to Contact the Firm

7 August 2019

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Abiomed, Inc. (NASDAQ: AMBD) securities between January 31, 2019 and July 31, 2019 (the “Class Period”).  Investors have until October 7, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

 

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?